SEC Filing Details
Document Details
Form
Filing Date
Jun 18, 2026
Document Date
Jun 15, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Lyell Immunopharma, Inc.
Issuer
LYELL IMMUNOPHARMA, INC.
Filer
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD